Express Scripts is “looking at strategic alternatives” for some of its non-core businesses, which include international ventures, UBC and PolyMedica.

In this issue, we present another installment of our quarterly review of medical device and in vitro diagnostics/research dealmaking-for July-September 2007. Our data are derived from Windhover's Strategic Transactions Database.

Medco is developing data that could accelerate the adoption of personalized medicine--as a way to make itself more relevant to customers and the lives they represent. Armed with infrastructure from its mail pharmacy business and access to medical information on large groups of people, it is financing and conducting studies to show the value of pharmacogenomic tests in improving clinical outcomes. By so doing, it could become an incredible enabler of companies pursuing personalized medicine.

New spine company Globus raises $110 million from Clarus Ventures; Medco Health Solutions acquires PolyMedica Corp. for $1.5 billion; Olympus' long-awaited capsule endoscope receives US regulatory clearance; Concentric Medical launches another iteration of its Merci Retriever for ischemic stroke.